tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsPositive Outlook on FibroBiologics, Inc. Due to Strategic Positioning and Clinical Progress in Fibroblast-Based Therapies
2M ago
FibroBiologics price target lowered to $10 from $12 at H.C. Wainwright
Premium
The Fly
FibroBiologics price target lowered to $10 from $12 at H.C. Wainwright
2M ago
FibroBiologics files patent application on generating multipotent cells
Premium
The Fly
FibroBiologics files patent application on generating multipotent cells
2M ago
PremiumCompany AnnouncementsFibroBiologics, Inc. Holds Annual Stockholders Meeting
3M ago
Premium
Company Announcements
FibroBiologics Appoints Jason D. Davis as CFO
3M ago
FibroBiologics appoints Jason Davis as CFO
Premium
The Fly
FibroBiologics appoints Jason Davis as CFO
3M ago
PremiumCompany AnnouncementsFibroBiologics Reports 2024 Financial Results and Updates
6M ago
FibroBiologics announces advancement in results of brain tissue repair
Premium
The Fly
FibroBiologics announces advancement in results of brain tissue repair
6M ago
Premium
Ratings
Promising Prospects for FibroBiologics, Inc.: Novel Fibroblast-Based Therapies and Strategic Advancements Underpin Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100